Gastrointestinal Lymphoma in Tertiary Gastroenterology Center: Epidemiological, Clinical and Endoscopic Features

Open access


Introduction. Within the heterogeneous group of extra-nodal lymphoma, the gastrointestinal tract is the most frequently involved extranodal site accounting for 30-50% of all extranodal cases. Gastrointestinal involvement most oftenoccurs secondarily, while the primary gastrointestinal lymphomasare relatively rare accounting for 30%-45% of all extranodal lymphomas and 0.9% of all gastrointestinal tumors. Within the gastrointestinal tract, lymphoma can arise in any region but the stomach is the most commonly involved organ being affected in 50-70% of all the gastrointestinal lymphomas, followed by the small intestine and ileocecal region. The aim of the study was to analyze and present data regarding the endoscopic aspects and clinical presentation of patients with gastrointestinal lymphoma.

Methods. We retrospectively reviewed the medical records of patients with primary or secondary gastrointestinal lymphoma diagnosed at our Clinic over a fifteen-year period (January 1, 1999 to December 31, 2013). We analyzed the demographic data, clinical presentation, anatomic distribution, endoscopic aspect of the lesion, extension of the neoplastic process and occurrence of different histological subtypes.

Results. We discovered 18 patients with gastrointestinal lymphoma (7 males and 11 females). Fourteen patients (77.7%) were considered primary, while 4 patients (22.2%) were considered secondary gastrointestinal lymphoma. The stomach was affected in 14 cases (11 primary and 3 secondary), there were 2 duodenal lymphomas, 1 lymphoma of the terminal ileum and 1 peritoneal lymphoma. In most patients (10) massive and diffuse gastrointestinal infiltration was diagnosed, 5 patients had ulcerated lesions in the stomach and 3 patients presented with polyploid mass. Six patients presented with upper gastrointestinal bleeding, 1 patient with biliary tract obstructtion, one patient with protein losing enteropathy, malabsorptionand consecutive bowel perforation and one patient presented only with ascites and pleural effusion. All the malignant lymphomas were Non-Hodgkin type and among them we registered only one T-cell lymphoma. Being diagnosed in 6 patients (33.33%), diffuse large B-cell lymphoma was the most prevalent histological type. The lymphoma was limited to the gastrointestinal tract in 6 patients, 7 patients had regional nodal involvement, in 2 patients there was an intra-abdominal spread and in 3 patients there was an extra-abdominal dissemination. Most patients received chemotherapy and only 2 patients were treated surgically. Two patients had rapidly progressive clinical course and lethal outcome shortly after the diagnosis was established and before chemotherapy was administered.

Conclusion. The gastrointestinal lymphoma has a variable clinical presentation and endoscopic aspect that often makes the diagnosis challenging. Substantial level of diagnostic awareness and comprehensive clinical approach are necessary in order to establish the correct diagnosis, provide appropriate treatment and prolong survival.

1. Ding W, Zhao S, Wang J, et al. Gastrointestinal Lymphoma in Southwest China: Subtype Distribution of 1.010 Cases Using the WHP (2008) Classification in a Single Institution. ActaHeaematol 2016; 135(1):21-8. doi: 10.1159/000437130. Epub 2015 Aug 15.

2. Rotaru I, Ciurea T, Foarfa C, et al. The diagnostic characteristics of a group of patients with primary gastric lymphoma: Macroscopic, histopathological and immunohistochemical aspects, Rom J Morphol Embryol 2012; 53(2): 343-350.

3. Singh D, Kumar L, Goyal H, et al. Primary extranodal non-Hodgkin’s lymphoma in northern India. Proc Am Soc ClinOncol 2003; 22: 2457.

4. Temmim L, Baker H, Amanguno H, et al. Clinicopathological Features of Extranodal Lymphomas: Kuwait Experience. Oncology 2004; 67: 382-389.

5. Al Shemmari SH, Ameen RM, Sajnani KP. Extranodal lymphoma: a comparative study. Hematology 2008; 13: 163-169.

6. Aoki R, Karube K, Sugita Y, et al. Distribution of malign-nant lymphoma in Japan: Analysis of 2260 cases, 2001-2006. PatholInt 2008; 58: 174-182.

7. Gross SA, Zhu X, Bao L, et al. A prospective study of 728 cases of non-Hodgkin lymphoma from a single laboratory in Shanghai, China. Int J Hematol 2008; 88: 165-173.

8. Lal A, Bhurgri Y, Vaziri I, et al. Extranodal non-Hodgkin’s lymphomas-a retrospective review of clinico-pathologic features and outcomes in comparison with nodal non-Hodgkin’s lymphomas. Asian Pac J Cancer Prev 2008; 9: 453-458.

9. Fujita A, Tomita N, Fujita H, et al. Features of primary extra-nodal lymphoma in Kanagawa, a human T-cell leukemia virus type 1 nonendemic area in Japan. Med Oncol 2009; 26: 49-54.

10. Chen W, Tsai W, Chao T. The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan. Ann Hematol 2010; 89: 553-562.

11. Yoon S, Suh C, Lee D, et al. Distribution of lymphoid neoplasms in the Republic of Korea: Analysis of 5318 cases according to the World Health Organization classification. Am J Hematol 2010; 85: 760-764.

12. Yun J, Kim SJ, Kim JA, et al. Clinical features and treatment outcomes of non-Hodgkin’s lymphomas involving rare extranodal sites: a single-center experience. ActaHaematol 2010; 123: 48-54.

13. Arora N, Manipadam MT, Pulimood A, et al. Gastrointestinal lymphomas: Pattern of distribution and histological subtypes: 10 years experience in a tertiary centre in South India. Ind J PatholMicrobiol 2011; 54: 712-719.

14. Nagi AH, Al Minawy L, Naseem N, et al. A study of the morphological patterns of extranodal non-Hodgkin lymphoma in Pakistani and Saudi populations. Biomedica 2010; 26: 118-123.

15. Yaqo RT, Hughson Md, Sulayvani FK, Al-Allwai NA. Malignant lymphoma in Northern Iraq: A retrospective analysis of 270 cases according to the World Health Organization classification. Ind J Cancer 2011; 48: 446-451.

16. Yang QP, Zhang WY, Yu JB, et al. Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institution. Diagnostic Pathology 2011; 6: 77.

17. Lee WK, Lau EW, Duddalwar VA, et al. Ho, “Abdominal manifestations of extranodal lymphoma: spectrum of imaging findings,” American Journal of Roentgenology 2008; 191(1): 198-206.

18. Crump M, Gospodarowicz M, Shepherd FA. Lymphoma of the gastrointestinal tract. SeminOncol 1999; 26: 324-337.

19. Koch P, del Valle F, Berdel WE, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J ClinOncol 2001; 19: 3861-3873.

20. d’Amore F, Brincker H, Gronbaek K, et al. Non-Hodgkin’s lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish lymphoma study group. J ClinOncol 1994; 12: 1673-1684.

21. Wu XC, Andrews P, Chen VW, Groves FD. Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific Islanders in the United States: anatomic site and histology differences. Cancer Epidemiol 2009; 33: 337-346.

22. Chbani L, Hafid I, Berraho M, et al. Digestive cancers in Morocco: Fez- Boulemane region. Pan Afr Med J 2012; 13: 46.

23. Ghai S, Pattison J, Ghai S, et al. Primary gastrointestinal lymphoma: spectrum of imaging findings with pathologic correlation. Radiographics 2007; 27: 1371-1388.

24. Gollub MJ. Imaging of gastrointestinal lymphoma. RadiolClin North Am 2008; 46: 287-312.

25. Wang GB, Xu GL, Luo GY, et al. Primary intestinal non-Hodgkin’s lymphoma: A clinicopathologic analysis of 81 patients. World J Gastroenterol 2011; 17(41): 4625-4631. doi: 10.3748/wjg.v17.i41.4625.

26. Herrmann R, Panahon AM, Barcos MP, et al. Gastrointestinal involvement in non-Hodgkin’s lymphoma, Cancer, 1980; 46(1): 215-222.

27. Dawson IM, Cornes JS, Morson BC. Primary malignant tumors of the intestinal tract. Br J Surg 1961; 49: 80-89.

28. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphoma. Cancer 1972; 29: 252-260.

29. Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer 1978; 42: 693-707.

30. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin’s disease Staging Classification. Cancer Res 1971; 31: 1860-1861. (ann Arbor)

31. Warrick J, Luo J, Robirds D, et al. Gastrointestinal lymphomas in a North American population: clinicopathologic features from one majorCentral-idwestern United States tertiary care medical center. Diagn Pathol 2012; 7: 76. doi: 10.1186/1746-1596-7-76.

32. Isikdogan A, Ayyildiz O, Buyukcelik A, et al. Non-Hodgkin’s lymphoma in south-east Turkey: clinicpathologic features of 490 cases. Ann Hematol 2004; 83: 265-269.

33. Ducreux M, Boutron MC, Piard F, et al. A 15 year series of gastrointestinal non-Hodgkins lymphoma: A population-based study. Br J Cancer 1998; 77: 511-514.

34. Papaxoinis G, Papageorgiou S, Rontogianni D, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: a clinicopathologic study of 128 cases in Greece. A Hellenic Cooperative Oncology Group study (HeCOG). Leuk Lymphoma 2006; 47: 2140-2146.

35. Banfi A, Bonadonna G, Carnevali G, et al. Preferential sites of involvement and spread in malignant lymphomas. Eur J Cancer 1968; 4: 319-324.

36. Padhi S, Paul TR, Challa S, et al. Primary extra nodal non Hodgkin lymphoma: a 5 year retrospective analysis. Asian Pac J Cancer Prev 2012; 13(10): 4889-95. PMID:23244076.

37. Salem P, el-Hashimi L, Anaissie E, et al. Primary small intestinal lymphoma in adults. A comparativestudy of IPSID versus non-IPSID in the Middle East. Cancer 1987; 59: 1670.

38. Ogwang MD, Bhatia K, Biggar RJ, Mbulaiteye SM. Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer 2008; 123: 2658.

39. Dotlic S, Perry AM, Petrusevska G, et al. Classification of non-Hodgkin lymphoma in South-eastern Europe: review of 632 cases from the international non-Hodgkin lymphoma classification project. Br J Haematol 2015; 171(3): 366-372. doi: 10.1111/bjh.13586.PMID:26213902.

40. Adamson P, Bray F, Costantini AS, et al. Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe. European Journal of Cancer 2007; 43: 391-401.

41. Morton LM, Wang SS, Devesa SS, et al. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006; 107: 265-276.

42. Nakamura S, Matsumoto T, Iida M, et al. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer 2003; 97: 2462-2473.

43. Howell JM, Auer-Grzesiak I, Zhang J, et al. Increasing incidence rates, distribution and histological characteristics of primary gastrointestinal non-Hodgkin lymphoma in a North American population. Can J Gastroenterol 2012; 26: 452-456.

44. Jemal A, Tiwari RC and Murray T. Cancer statistics. CA Cancer J Clin 2004; 54: 8-29.

45. Krol ADG, le Cessie S, Snijder S, et al. Primary extranodal non-Hodgkin’s lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Ann Oncol 2003; 14: 131-139.

46. Chandran RR, Raj EH, Chaturvedi HK. Primary gastrointestinal lymphoma: 30-year experience at the Cancer Institute, Madras, India. J Surg Oncol 1995; 60(1): 41-9. PMID:7666666.

47. Raina V, Sharma A, Vora A, et al. Primary gastrointestinal non Hodgkin’s lymphoma chemotherapy alone an effective treatment modality: experience from a single centre in India. Indian J Cancer 2006; 43(1): 30-5. PMID:16763360.

48. Al Diab AR, Aleem A, Qayum A, et al. Clinico-Pathological Pattern of Extranodal Non-Hodgkin’s Lymphoma in Saudi Arabia. Asian Pacific J Cancer Prev 2011; 12(12): 3277-3282.

49. Geramizadeh B, Keshtkar Jahromi M. Primary Extranodal Gastrointestinal Lymphoma: A Single Center Experience from Southern Iran-Report of Changing Epidemiology. Arch Iran Med 2014; 17(9): 638-639. doi: 0141709/AIM.0011.

50. Medina-Franco H, Germes SS, Maldonado CL. Prognostic factors in primary gastric lymphoma. Annals of surgical oncology 2007; 14(8): 2239-2245.

51. Chan JK. The new World Health Organization classification of lymphomas: the past, the present and the future. Hematological oncology 2001; 19(4): 129-150.

52. Rohatiner A, d’Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classifications of GIT lymphoma. Ann Oncol 1994; 5(5): 397-400.

53. Muller AM, Ihorst G, Mertelsmann R and Engelhardt M. Epidemiology of non-Hodgkin’s lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 2005; 84: 1-12.

54. Santacroce L, Cagiano R, Del Prete R, et al. Helicobacter pylori infection and gastric MALTomas: an up-to-date and therapy highlight. La Clinica terapeutica 2008; 159(6): 457-462.

55. Wundisch T, Kim TD, Thiede C, et al. Etiology and therapy of Helicobacter pylori-associated gastric lymphomas. Annals of hematology 2003; 82(9): 535-545.

56. Sagaert X, Van Cutsem E, De Hertogh G, et al. Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development. Nat Rev Gastroenterol Hepatol 2010; 7: 336-346.

57. Ferreri AJ, Zucca E. Marginal-zone lymphoma. Crit Rev Oncol Hematol 2007; 63(3): 245-256.

58. Chott A, Dragosics B, Radaszkiewicz T. Peripheral T-cell lymphomas of the intestine. Am J Pathol 1992; 141(6): 1361-1371. PMID:1466400.

59. Shet T, Karpate A, Bal M, et al. Primary intestinal T cell lymphomas in Indian patients-in search of enteropathic T cell lymphoma. Indian J Pathol Microbiol 2010; 53(3): 455-459. doi: 10.4103/0377-4929.68274.

Journal Information


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 193 190 14
PDF Downloads 99 96 10